Answers are grounded in this paper and cite their sources.
New chelating radical ligands pzNNH, pzINH, and pzbisINH (3-pyrazolyl nitronyl nitroxide, 3-pyrazolyl imino nitroxide, and pyrazole-3,5-diyl bis(imino nitroxide), respectively) were prepared. Complexation of these ligands with Ag+ gave [Ag(pzNN)]n, [Ag(pzIN)]6, and [Ag(pzbisIN)]n containing the corresponding anionic forms of the ligands. From the X-ray crystal structure analysis, [Ag(pzIN)]6 was characterized as a dimer of almost planar triangular moieties where the pyrazolate worked as a bridge, and metal-metal bonds brought about dimerization of triangles. [Ag(pzbisIN)]n was characterized as a uniform zigzag chain consisting of pyrazolate bridges and Ag ions with a cis-Npz-Ag-Npz coordination structure. Antiferromagnetic interactions observed could be analyzed based on the structures determined for both compounds. Ferromagnetic coupling was observed in [Ag(pzNN)]n, and a polymeric structure was assumed although the crystal structure could not be determined. Novel supramolecular architectures using pyrazolate-substituted imino nitroxides have been developed, using the unique coordinative versatility of the pyrazolate derivatives
No takes yet. Share an insight, caveat, or question.
Yamada et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: